Page last updated: 2024-10-22

albuterol and Encephalopathy, Traumatic

albuterol has been researched along with Encephalopathy, Traumatic in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gahagen, RE1
Beardsley, AL1
Maue, DK1
Ackerman, LL1
Rowan, CM1
Friedman, ML1

Other Studies

1 other study available for albuterol and Encephalopathy, Traumatic

ArticleYear
Early-Onset Ventilator-Associated Pneumonia in Pediatric Severe Traumatic Brain Injury.
    Neurocritical care, 2023, Volume: 39, Issue:3

    Topics: Albuterol; Brain Injuries, Traumatic; Child; Humans; Intensive Care Units; Intensive Care Units, Ped

2023